Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...
Siemens Medical Solutions Ultrasound Division’s syngo Arterial Health Package (AHP) application for cardiovascular risk ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
GE Healthcare Medical Diagnostics’ VISIPAQUE is reportedly the only isosmolar contrast medium (IOCM) available in the U.S. With an osmolality equal to that of blood, VISIPAQUE was designed for patient safety and comfort and is also formulated with sodium and calcium in a ratio equivalent to blood.
St. Jude Medical Inc. announced that the FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 6, 2007 – Boston Scientific Corp. announced at the ESC 2007 conference in Vienna, Austria, that results from ...
September 5, 2007 - Results from a study on acute cardiogenic pulmonary edema, or "fluid on the lung," presented at the ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 5, 2007 - The National Institutes of Health has awarded its $5 million Bioengineering Research Partnership ...
September 5, 2007 - Edwards Lifesciences Corp. announced that it has received CE Mark approval for European commercial ...
September 4, 2007- New recommendations released today in the Journal of the American Society of Echocardiography further support the role of stress echo in accurately identifying coronary artery disease (CAD), determining prognosis of patients with known or suspected CAD, in addition to providing recommendations for optimizing imaging.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 4, 2007 - Analysis of clinical trials showed the Cypher Sirolimus-eluting coronary stent was associated with ...
September 4, 2007 – At the European Society of Cardiology’s (ESC) annual congress, Royal Philips Electronics ...
September 4, 2007 - The first few minutes are instrumental in emergency situations and a new portable ultrasound device ...